Vascular Endothelial Growth Factor, thrombelastography and coagulation in the context of etiology, outcome and clinical course of patients after circulatory arrest

Vascular Endothelial Growth Factor, thrombelastography and coagulation in the context of etiology, outcome and clinical course of patients after circulatory arrest - VEPCA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033234

Enrollment

150

Registered

2023-12-18

Start date

2024-02-01

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I46

Interventions

Group 1: Patients after Cardiac Arrest with Return of spontaneous circulation Mesurement of Vascular Endothelial Growth Factor (VEGF) and other laboratory parameters on admission and within the clini

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Return of spontaneous circulation or decision to initiate ECLS (extracorporeal life support)

Exclusion criteria

Exclusion criteria: - Age < 18 years - pregnancy - Patient, legal guardians or authorized representatives do not give informed consent or relatives indicate that the presumed patient wishes contradict a participation.

Design outcomes

Primary

Measure	Time frame
Outcome at hospital discharge, according to Cerebral Performance Category (CPC)	—

Secondary

Measure	Time frame
- Outcome at 3 months according to CPC - Prognosis of hypoxic-ischemic encephalopathy - Analysis of laboratory parameter and clinical findings in regard to coagulation. - Organ failures and severity of post cardiac arrest syndrome.	—

Countries

Germany

Contacts

Public ContactVolker Gebhardt

BG-Klinikum Unfallkrankenhaus Berlin

info@ukb.de03056810

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026